COMMUNIQUÉS West-GlobeNewswire

-
PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform to Standardize Histological Assessment in Ulcerative Colitis Trials
23/09/2025 -
Confluent Health Appoints Jim Greenwood as New Board Chair
23/09/2025 -
Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB
23/09/2025 -
Major Shareholder Announcement
23/09/2025 -
Biofrontera Inc. Engages Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
23/09/2025 -
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
23/09/2025 -
Plum Tree Leads the Way in Team-Based Child Therapy and Multidisciplinary Testing
23/09/2025 -
H.H.C. Group Launches “Proof in the Pudding” Savings Program for Prospective Client TPAs, Stop-Loss and Self-Insured Payors
23/09/2025 -
Trethera Receives $1.8 Million NIH Grant to Advance TRE-515 Development for Crohn’s Disease
23/09/2025 -
Human Appeal USA Expands its Domestic Programs with New Locations in Maryland and Virginia to Mobilize Humanitarian Support Nationwide
23/09/2025 -
CMS Grants Transitional Pass-Through Status for Gozellix
23/09/2025 -
Remedy's Nutrition® Launches Advanced Herbal Parasite Cleanse Formula to Support Natural Digestive Wellness and Internal Cleansing
23/09/2025 -
Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development
23/09/2025 -
Innovate GBM’s 2025 Investment Playbook Year to Date Review: Building a New Market for Brain Cancer Investments and Breakthroughs
23/09/2025 -
NeuraClick Welcomes Biotech Veteran Daniel M. Bradbury as Strategic and Metabolic Programs Advisor
23/09/2025 -
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combination on September 22, 2025
23/09/2025 -
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
23/09/2025 -
BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer
23/09/2025 -
Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup
23/09/2025
Pages